Arun V J: Fresh Whole Blood vs Evidence-Based Transfusion
Arun V. J.,Specialist at MVR Cancer Centre and Research Institute, Member of International Society of Blood Transfusion (ISBT) and ADRP: The Association for Blood Donor Professionals, Doctor at Malabar Medical College Hospital and Research Centre, shared a post on LinkedIn:
“Who Are You To Decide The Treatment Of My Patient?
I want a Jurassic-era treatment.
Iykyk
This is a typical conversation with an old-school consultant.
Hb: 10.5; all coagulation profile normal.
Post op patient with oozing, completely hemodynamically stable.
Request was for fresh whole blood.
(No, we don’t unnecessarily transfuse blood. We follow international guidelines.)
(No, nothing is done on a whim)
Anything out of the ordinary, I make it a point to call and enquire if there was something we missed.
I asked if we should work up for any coagulopathy and switch to components if needed (very politely and subserviently, as Indian Healthcare demands).
Response: We rely too much on Jurassic Era idiocy masked as intuition or Gut feeling.
Patients have not died till now IN FRONT of us due to blood transfusion (which is not a justification).
How do you handle such scenarios?
Have you come across such a difficult conversation?”

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition